SCHEMBL7803483

SCHEMBL7803483

O=C(CC1CCCOC1=O)c1ccccc1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 3/20 0.49
ALDH1A1 P00352 3/20 0.49
L3MBTL1 Q9Y468 2/20 0.49
KDM4E B2RXH2 3/20 0.47
CTNNB1 P35222 2/20 0.41
WNT3A P56704 1/20 0.41
HPGD P15428 3/20 0.40
MCL1 Q07820 1/20 0.40
KCNH2 Q12809 1/20 0.39
TP53 P04637 2/20 0.39
MAPK1 P28482 3/20 0.39
MEN1 O00255 2/20 0.39
ALOX15 P16050 2/20 0.39
KMT2A Q03164 2/20 0.39
SMN1; SMN2 Q16637 2/20 0.39
CYP3A4 P08684 1/20 0.39
CES1 P23141 1/20 0.39
TDP1 Q9NUW8 1/20 0.39
TSHR P16473 2/20 0.39
HSD17B10 Q99714 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3601493 0.91 MAPT (0.47) MAPTALDH1A1L3MBTL1KDM4ECTNNB1
SCHEMBL11838776 0.76 KDM4E (0.66) MAPTALDH1A1L3MBTL1KDM4EHPGD
SCHEMBL29287392 0.76 MCL1 (0.57) MAPTALDH1A1L3MBTL1HPGDMCL1
SCHEMBL3327919 0.75 KDM4E (0.73) MAPTALDH1A1L3MBTL1KDM4EHPGD
SCHEMBL3593228 0.75 L3MBTL1 (0.63) MAPTALDH1A1L3MBTL1KDM4EHPGD
SCHEMBL2978224 0.74 MAOB (0.46)
SCHEMBL11836745 0.74 KDM4E (0.71) MAPTALDH1A1L3MBTL1KDM4EHPGD
SCHEMBL11863329 0.74 KDM4E (0.71) MAPTALDH1A1L3MBTL1KDM4EHPGD
SCHEMBL3630240 0.74 FKBP1A (0.36) MAPK1KMT2A
SCHEMBL18357628 0.73 HPGD (0.61) MAPTALDH1A1L3MBTL1HPGDMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0613465-B1 1,3-SUBSTITUTED CYCLOALKENES AND CYCLOALKANES AS CENTRAL NERVOUS SYSTEM AGENTS WARNER LAMBERT CO (US) 2001-10-04 EP disclosed
US-5409931-A Dopaminergic, antipsychotic and antihypertensive agents WARNER-LAMBERT COMPANY (US) 1995-04-25 US disclosed
EP-0613465-A1 1,3-SUBSTITUTED CYCLOALKENES AND CYCLOALKANES AS CENTRAL NERVOUS SYSTEM AGENTS WARNER-LAMBERT COMPANY (US) 1994-09-07 EP disclosed
US-5314896-A Dopaminergic agents, antipsychotic and hypotensive agents WARNER-LAMBERT COMPANY (US) 1994-05-24 US disclosed
EP-0545095-A1 1,3-Substituted cycloalkenes and cycloalkanes as central nervous system agents WARNER-LAMBERT COMPANY (US) 1993-06-09 EP disclosed
WO-1993010092-A1 1,3-SUBSTITUTED CYCLOALKENES AND CYCLOALKANES AS CENTRAL NERVOUS SYSTEM AGENTS WARNER-LAMBERT COMPANY (US) 1993-05-27 WO disclosed